Amiloride evokes significant natriuresis and weight loss in kidney transplant recipients with and without albuminuria

Am J Physiol Renal Physiol. 2023 Oct 1;325(4):F426-F435. doi: 10.1152/ajprenal.00108.2023. Epub 2023 Aug 10.

Abstract

Albuminuria in kidney transplant recipients (KTRs) is associated with hypertension and aberrant glomerular filtration of serine proteases that may proteolytically activate the epithelial Na+ channel (ENaC). The present nonrandomized, pharmacodynamic intervention study aimed to investigate if inhibition of ENaC increases Na+ excretion and reduces extracellular volume in KTRs dependent on the presence of albuminuria. KTRs with and without albuminuria (albumin-to-creatinine ratio > 300 mg/g, n = 7, and <30 mg/g, n = 7, respectively) were included and ingested a diet with fixed Na+ content (150 mmol/day) for 5 days. On the last day, amiloride at 10 mg was administered twice. Body weight, 24-h urine electrolyte excretion, body water content, and ambulatory blood pressure as well as plasma renin, angiotensin II, and aldosterone concentrations were determined before and after amiloride. Amiloride led to a significant decrease in body weight, increase in 24-h urinary Na+ excretion, and decrease in 24-h urinary K+ excretion in both groups. Urine output increased in the nonalbuminuric group only. There was no change in plasma renin, aldosterone, and angiotensin II concentrations after amiloride, whereas a significant decrease in nocturnal systolic blood pressure and increase in 24-h urine aldosterone excretion was observed in albuminuric KTRs only. There was a significant correlation between 24-h urinary albumin excretion and amiloride-induced 24-h urinary Na+ excretion. In conclusion, ENaC activity contributes to Na+ and water retention in KTRs with and without albuminuria. ENaC is a relevant pharmacological target in KTRs; however, larger and long-term studies are needed to evaluate whether the magnitude of this effect depends on the presence of albuminuria.NEW & NOTEWORTHY Amiloride has a significant natriuretic effect in kidney transplant recipients (KTRs) that relates to urinary albumin excretion. The epithelial Na+ channel may be a relevant direct pharmacological target to counter Na+ retention and hypertension in KTRs. Epithelial Na+ channel blockers should be further investigated as a mean to mitigate Na+ and water retention and to potentially obtain optimal blood pressure control in KTRs.

Keywords: diuretics; epithelial Na+ channel; hyperkalemia; protease; proteinuria.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria
  • Aldosterone
  • Amiloride / pharmacology
  • Amiloride / therapeutic use
  • Angiotensin II
  • Blood Pressure Monitoring, Ambulatory
  • Body Weight
  • Epithelial Sodium Channels
  • Humans
  • Hypertension*
  • Kidney Transplantation* / adverse effects
  • Natriuresis
  • Renin
  • Sodium / metabolism
  • Water
  • Water-Electrolyte Imbalance*
  • Weight Loss

Substances

  • Amiloride
  • Renin
  • Aldosterone
  • Angiotensin II
  • Sodium
  • Water
  • Epithelial Sodium Channels